Interview: Hemogenyx

This post was written by Zak Mir, a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator

The Hemogenyx breakthrough heralds the double whammy of the end of chemotherapy and the need for bone marrow transplants to treat blood diseases, as well as a new investment situation.

Dr. Vladislav Sandler is the founder and CEO of Hemogenyx and Adrian Beestan, Director at Hemogenyx Pharmaceuticals talk to host Zak Mir about the company’s mission.

 

[youtube https://www.youtube.com/watch?v=6kG7G_Hwo9U&w=560&h=315]
Zak Mir

Zak Mir

About Me

Zak Mir is a Technical Analyst, Events Host, Presenter, CEO Interviewer and established Market Commentator. Zak presents the daily Bulletin Board Heroes which can be seen here at Share Talk

Recent Posts

Zak Mir Twitter

RT @ShareTalkNews: @PantherMetals (#PALM.L) Plans to List #Australian Assets on the @ASX 🇦🇺 @darrenhazelwood Chief Executive... Read More

Apr 15 2021, 10:03 am

RT @ShareTalkNews: #Coinbase fever and an associated new high for #Bitcoin helped the cause as... Read More

Apr 15 2021, 9:57 am

RT @ShareTalkNews: Market Summary >@BrandShieldltd LON #BRSD 24.00 GBX +3.00 (14.29%)⤴️ 15 Apr, 09:32 BST ·Disclaimer https://t.co/O72hDa8… Read More

Apr 15 2021, 8:44 am

Bulliten Board Heroes

Malcare WordPress Security